SCHEMBL30107948

SCHEMBL30107948

CS(=O)(=O)c1nccc(-c2ccco2)n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.58
KDM4E B2RXH2 8/20 0.58
HSD17B10 Q99714 5/20 0.58
MAPT P10636 5/20 0.58
RAB9A P51151 3/20 0.58
HPGD P15428 2/20 0.58
NPC1 O15118 2/20 0.58
JAK2 O60674 1/20 0.58
TP53 P04637 1/20 0.58
STAT3 P40763 1/20 0.58
HTT P42858 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
TLR8 Q9NR97 1/20 0.58
GLA P06280 1/20 0.50
GAA P10253 1/20 0.50
MAPK1 P28482 1/20 0.49
CYP19A1 P11511 1/20 0.42
PDE10A Q9Y233 1/20 0.41
BLM P54132 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21621272 1.00 ALDH1A1 (0.58) ALDH1A1KDM4EHSD17B10MAPTRAB9A
SCHEMBL2199524 0.78 PTGS2 (0.38) ALDH1A1KDM4EHSD17B10MAPTRAB9A
SCHEMBL28345474 0.77 KDM4E (0.39) ALDH1A1KDM4EHSD17B10MAPTRAB9A
SCHEMBL5022932 0.77 MAPT (0.65) ALDH1A1KDM4EHSD17B10MAPTRAB9A
SCHEMBL30209584 0.77 KDM4E (0.39) ALDH1A1KDM4EHSD17B10MAPTRAB9A
SCHEMBL4056111 0.76 ADORA2B (0.65) ALDH1A1KDM4EHSD17B10MAPTRAB9A
SCHEMBL2199521 0.75 GRM4 (0.59) ALDH1A1KDM4EHSD17B10MAPTRAB9A
SCHEMBL4447801 0.75 BPTF (0.54) ALDH1A1KDM4EHSD17B10RAB9AHPGD
SCHEMBL23998422 0.74 ALDH1A1 (0.48) ALDH1A1KDM4EHSD17B10MAPTRAB9A
SCHEMBL5361055 0.73 KDM4E (0.52) ALDH1A1KDM4EHSD17B10RAB9AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022203399-A1 ADENOSINE A2A RECEPTOR ANTAGONIST AND USE THEREOF 주식회사 스탠다임 2022-09-29 WO disclosed